Safety aspects of local endobronchial allergen challenge in asthmatic patients.
Local endobronchial allergen challenge is being increasingly used to investigate the role of allergic inflammation in asthma. However, little information is available about the safety of this procedure and the changes induced in airway physiology. BAL and biopsy were performed at 10 min and at 4 to 6 h, or 24 h after segmental allergen challenge in 49 patients with atopic asthma. Two hours after challenge, FEV1 was reduced from 97.6 +/- 13.9 (mean +/- SD) to 83.4 +/- 21.7% predicted. FEV1 remained reduced at 4 to 6 h (87.7 +/- 20.4%), but it had nearly returned to baseline by 24 h (93.2 +/- 14.0%). When endobronchial challenge was combined with BAL and biopsy, the initial fall in FEV1 was slightly greater (from 101.8 +/- 14.2 to 78.5 +/- 13.6%). Bronchial responsiveness to methacholine was measured in 10 subjects, and it showed a twofold increase 24 h after local challenge and lavage. Significant changes in FEV1 and methacholine PC20 were still detectable 72 h after challenge. Widespread wheezing occurred in 29% of the subjects, but none of the them had to be admitted to hospital. We conclude that local endobronchial allergen challenge, although producing measurable changes in airway physiology, is in general well tolerated and is an acceptable method to investigate airway pathophysiologic processes in patients with mild to moderate asthma.
Krug
N
N
Immunopharmacology Group, University Medicine, Southampton General Hospital, United Kingdom.
Teran
L M
LM
Redington
A E
AE
Gratziou
C
C
Montefort
S
S
Polosa
R
R
Brewster
H
H
Howarth
P H
PH
Holgate
S T
ST
Frew
A J
AJ
Carroll
M P
MP
D000328:Adult; D001249:Asthma / Q000503:physiopathology*; D001706:Biopsy; D001980:Bronchi / Q000473:pathology; D001985:Bronchial Provocation Tests / Q000379:methods; D018893:Bronchoalveolar Lavage; D001999:Bronchoscopy; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D008297:Male; D012189:Retrospective Studies; D012449:Safety